Leqembi

Eisai wins over European regulators on Alzheimer’s drug Leqembi
BioPharma Dive
Thu, 11/14/24 - 10:28 pm
Eisai
Biogen
Leqembi
Alzheimer's disease
5 Reasons Biogen’s Shares Have Dropped 36% in 2024
BioSpace
Thu, 11/14/24 - 11:19 am
Biogen
Leqembi
Qalsody
Skyclary
Zurzuvae
Spinraza
Eisai Cuts Fiscal 2024 Guidance for Biogen-Partnered Leqembi as Sales Disappoint Analysts
BioSpace
Sun, 11/10/24 - 09:27 pm
Eisai
Biogen
Leqembi
earnings
Alzheimer's disease
Eisai dials back forecasts for Alzheimer's drug Leqembi
Pharmaphorum
Fri, 11/8/24 - 11:38 am
Eisai
earnings
Leqembi
Alzheimer's disease
Eisai, Biogen eye 2025 approval for Leqembi autoinjector
Pharmaphorum
Fri, 11/1/24 - 10:57 am
Eisai
Biogen
Leqembi
Alzheimer's disease
FDA
Leqembi's vial design could result in hundreds of millions in annual Medicare waste: study
Fierce Pharma
Mon, 10/14/24 - 11:13 pm
Eisai
Biogen
Leqembi
Alzheimer's disease
Eisai, Biogen's Leqembi nabs UK nod, but reimbursement remains elusive
Fierce Pharma
Thu, 08/22/24 - 11:45 am
Eisai
Biogen
Leqembi
UK
Alzheimer's disease
Driven by Leqembi, Biogen beats Q2 expectations, raises full-year outlook
Medical Marketing and Media
Thu, 08/1/24 - 11:21 pm
Biogen
earnings
Leqembi
After EU setback, Eisai/Biogen build case for Leqembi
Pharmaphorum
Wed, 07/31/24 - 10:25 am
Eisai
Biogen
Alzheimer's disease
Leqembi
Europe
Eisai 'extremely disappointed' by EMA's decision on Alzheimer's drug
Biopharma Reporter
Tue, 07/30/24 - 11:37 am
Eisai
EMA
Europe
Leqembi
Biogen
Alzheimer's disease
Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe
Fierce Pharma
Fri, 07/26/24 - 11:15 am
Eisai
Biogen
Leqembi
Europe
Leqembi sales inch higher; Spark’s pivot leads to layoffs
BioPharma Dive
Fri, 07/12/24 - 11:29 am
Eisai
Biogen
Leqembi
Alzheimer's disease
Roche
Spark Therapeutics
gene therapy
layoffs
Leqembi gains approval for Alzheimer’s treatment in Israel
Pharmaceutical Business Review
Fri, 07/12/24 - 11:12 am
Eisai
Israel
Alzheimer's disease
Leqembi
BioArctic
Eisai and Biogen launch Alzheimer's drug Leqembi in China
Reuters
Fri, 06/28/24 - 11:18 am
Eisai
Biogen
Alzheimer's disease
Leqembi
China
What Would a Donanemab Approval Mean for Leqembi?
BioSpace
Mon, 06/24/24 - 10:47 am
Eli Lilly
donanemab
Biogen
Eisai
Leqembi
FDA
Alzheimer's disease
FDA accepts Eisai's subcutaneous Leqembi filing, sets January 25 decision date
Fierce Pharma
Mon, 06/10/24 - 11:19 am
Eisai
Biogen
Leqembi
FDA
Alzheimer's disease
Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
Reuters
Tue, 05/14/24 - 11:03 pm
Eisai
Biogen
Leqembi
FDA
Alzheimer's disease
Alzheimer's drug adoption in US slowed by doctors' skepticism
Reuters
Tue, 04/23/24 - 09:47 pm
Eisai
Biogen
Leqembi
physicians
Alzheimer's disease
Lilly Alzheimer's med glides out of Leqembi's slipstream with FDA adcomm request
Fierce Biotech
Wed, 04/17/24 - 09:58 pm
Eli Lilly
donanemab
Alzheimer's disease
Leqembi
Biogen
Eisai
FDA
Biogen and Eisai Fall Behind on Leqembi’s Subcutaneous BLA for Alzheimer’s
BioSpace
Mon, 04/1/24 - 12:14 pm
Biogen
Eisai
Alzheimer's disease
Leqembi

Pages